Revenue breakdown: Consumables And Parts (66.6%), System Revenue (33.2%), License Fees And Other (0.2%).
8-K
Sanuwave Health, Inc. announced record Q4 2025 revenues of $13.4 million (up 29.7% YoY) and full year 2025 revenues of $44.1 million (up 35.0% YoY), with Q4 GAAP operating income of $2.0 million and full year net income of $11.8 million. The company issued Q1 2026 revenue guidance of $9.6-10.3 million and full year 2026 guidance of $51.0-55.0 million.